Adaptive current tomography screens for breast cancer:
This article was originally published in Clinica
Executive Summary
A noninvasive device for breast cancer screening is being developed by Rensselaer Polytechnic Institute in Troy, New York. The device uses a technique called adaptive current tomography (ACT) which locates tumours by passing electrical current through breast tissue. Tumours "light up" because they conduct electricity four times as easily as healthy breast tissue. The Institute says that ACT has advantages over X-ray imaging which misses as many as 10% of breast tumours. ACT may also provide safe 24-hour monitoring whilst avoiding the risk of radiation exposure, reports the Daily Telegraph (February 2nd).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.